Haematological classification of the chronic myeloid leukaemias
Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions. The subtypes of CML are: o 1. Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+, BCR+, 5% are Ph−, BCR...
Gespeichert in:
Veröffentlicht in: | Baillière's clinical haematology 1987-12, Vol.1 (4), p.887-906 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 906 |
---|---|
container_issue | 4 |
container_start_page | 887 |
container_title | Baillière's clinical haematology |
container_volume | 1 |
creator | Shepherd, Patricia C.A. Ganesan, T.S. Galton, David A.G. |
description | Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions.
The subtypes of CML are:
o
1.
Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+,
BCR+, 5% are Ph−,
BCR+)
2.
Juvenile CML (extremely rare; Ph−,
BCR− in the few so far examined)
3.
Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−,
BCR− in the few so far examined)
4.
Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−,
BCR−
5.
Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly
BCR−. Significance of few reported
BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining.
Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential. |
doi_str_mv | 10.1016/S0950-3536(87)80031-8 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78050773</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0950353687800318</els_id><sourcerecordid>78050773</sourcerecordid><originalsourceid>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</originalsourceid><addsrcrecordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAopE3TpKcJTYMhTeIAnKM0dVggbUbSIu3fk31oV062bL9-7QehaYbvM5yVD2-4ojgllJS3nN1xjEmW8jM0PpUv0GUIXxjnvCB8hEaEkJxTOkazpYRW9s66T6OkTZSVIRgd8964LnE66deQqLV3nVFJuwXrTJNYGL6jzshwhc61tAGuj3GCPp4W7_Nlunp9fpk_rlKVM9qnJc2gqLhkWlc1iSVa1VTrupYFaySQnNZSqlwSQkulaV3pQpfxbs7KTNKckgm6OezdePczQOhFa4ICa2UHbgiCcUwxYyQO0sOg8i4ED1psvGml34oMix0ssYcldlQEZ2IPS_Comx4NhrqF5qQ6kor92aEP8ctfA14EZaBT0BgPqheNM_84_AFq2nur</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78050773</pqid></control><display><type>article</type><title>Haematological classification of the chronic myeloid leukaemias</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</creator><creatorcontrib>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</creatorcontrib><description>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions.
The subtypes of CML are:
o
1.
Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+,
BCR+, 5% are Ph−,
BCR+)
2.
Juvenile CML (extremely rare; Ph−,
BCR− in the few so far examined)
3.
Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−,
BCR− in the few so far examined)
4.
Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−,
BCR−
5.
Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly
BCR−. Significance of few reported
BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining.
Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</description><identifier>ISSN: 0950-3536</identifier><identifier>DOI: 10.1016/S0950-3536(87)80031-8</identifier><identifier>PMID: 3332855</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Blood Cell Count ; Bone Marrow - pathology ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology ; Leukemia, Myelomonocytic, Chronic - physiopathology ; Leukocyte Count ; Philadelphia Chromosome ; Prognosis ; Translocation, Genetic</subject><ispartof>Baillière's clinical haematology, 1987-12, Vol.1 (4), p.887-906</ispartof><rights>1987 Baillière Tindall</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</citedby><cites>FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3332855$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shepherd, Patricia C.A.</creatorcontrib><creatorcontrib>Ganesan, T.S.</creatorcontrib><creatorcontrib>Galton, David A.G.</creatorcontrib><title>Haematological classification of the chronic myeloid leukaemias</title><title>Baillière's clinical haematology</title><addtitle>Baillieres Clin Haematol</addtitle><description>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions.
The subtypes of CML are:
o
1.
Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+,
BCR+, 5% are Ph−,
BCR+)
2.
Juvenile CML (extremely rare; Ph−,
BCR− in the few so far examined)
3.
Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−,
BCR− in the few so far examined)
4.
Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−,
BCR−
5.
Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly
BCR−. Significance of few reported
BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining.
Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</description><subject>Blood Cell Count</subject><subject>Bone Marrow - pathology</subject><subject>Humans</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</subject><subject>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</subject><subject>Leukemia, Myelomonocytic, Chronic - physiopathology</subject><subject>Leukocyte Count</subject><subject>Philadelphia Chromosome</subject><subject>Prognosis</subject><subject>Translocation, Genetic</subject><issn>0950-3536</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1987</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1PwzAMhnMAjTH4CZN6QnAopE3TpKcJTYMhTeIAnKM0dVggbUbSIu3fk31oV062bL9-7QehaYbvM5yVD2-4ojgllJS3nN1xjEmW8jM0PpUv0GUIXxjnvCB8hEaEkJxTOkazpYRW9s66T6OkTZSVIRgd8964LnE66deQqLV3nVFJuwXrTJNYGL6jzshwhc61tAGuj3GCPp4W7_Nlunp9fpk_rlKVM9qnJc2gqLhkWlc1iSVa1VTrupYFaySQnNZSqlwSQkulaV3pQpfxbs7KTNKckgm6OezdePczQOhFa4ICa2UHbgiCcUwxYyQO0sOg8i4ED1psvGml34oMix0ssYcldlQEZ2IPS_Comx4NhrqF5qQ6kor92aEP8ctfA14EZaBT0BgPqheNM_84_AFq2nur</recordid><startdate>198712</startdate><enddate>198712</enddate><creator>Shepherd, Patricia C.A.</creator><creator>Ganesan, T.S.</creator><creator>Galton, David A.G.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198712</creationdate><title>Haematological classification of the chronic myeloid leukaemias</title><author>Shepherd, Patricia C.A. ; Ganesan, T.S. ; Galton, David A.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c275t-651e498a7ff9b327559b5ffbba47dae325baac2a3356cf5b9f4f65368761a5253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1987</creationdate><topic>Blood Cell Count</topic><topic>Bone Marrow - pathology</topic><topic>Humans</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics</topic><topic>Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology</topic><topic>Leukemia, Myelomonocytic, Chronic - physiopathology</topic><topic>Leukocyte Count</topic><topic>Philadelphia Chromosome</topic><topic>Prognosis</topic><topic>Translocation, Genetic</topic><toplevel>online_resources</toplevel><creatorcontrib>Shepherd, Patricia C.A.</creatorcontrib><creatorcontrib>Ganesan, T.S.</creatorcontrib><creatorcontrib>Galton, David A.G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Baillière's clinical haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shepherd, Patricia C.A.</au><au>Ganesan, T.S.</au><au>Galton, David A.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Haematological classification of the chronic myeloid leukaemias</atitle><jtitle>Baillière's clinical haematology</jtitle><addtitle>Baillieres Clin Haematol</addtitle><date>1987-12</date><risdate>1987</risdate><volume>1</volume><issue>4</issue><spage>887</spage><epage>906</epage><pages>887-906</pages><issn>0950-3536</issn><abstract>Chronic myeloid leukaemia (CML) includes five subtypes, and the term should be used in the same way as the term chronic lymphoid leukaemia to refer to a group of related conditions.
The subtypes of CML are:
o
1.
Chronic granulocytic leukaemia (CGL) (95% of all CML; 90% are Ph+,
BCR+, 5% are Ph−,
BCR+)
2.
Juvenile CML (extremely rare; Ph−,
BCR− in the few so far examined)
3.
Chronic neutrophilic leukaemia (CNL) (extremely rare; Ph−,
BCR− in the few so far examined)
4.
Chronic myelomonocytic leukaemia (CMML). CMML with low or normal leukocyte counts is classified as a myelodysplastic syndrome; CMML with high leukocyte count is both myelodysplastic and myeloproliferative. Ph−,
BCR−
5.
Atypical CML (aCML). Intermediate between CGL and CMML but has distinctive features. Ph−, mostly
BCR−. Significance of few reported
BCR+ uncertain. Markedly worse survival than CGL and probably worse than CMML. Definition needs refining.
Types 2, 3, 4 and 5 account for 5% of all CML. CGL, CMML, aCML and CNL can be diagnosed in the great majority of cases from the morphological profile of presentation peripheral blood films, but high-quality Romanowsky staining is essential.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>3332855</pmid><doi>10.1016/S0950-3536(87)80031-8</doi><tpages>20</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0950-3536 |
ispartof | Baillière's clinical haematology, 1987-12, Vol.1 (4), p.887-906 |
issn | 0950-3536 |
language | eng |
recordid | cdi_proquest_miscellaneous_78050773 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Blood Cell Count Bone Marrow - pathology Humans Leukemia, Myelogenous, Chronic, BCR-ABL Positive - blood Leukemia, Myelogenous, Chronic, BCR-ABL Positive - classification Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology Leukemia, Myelomonocytic, Chronic - physiopathology Leukocyte Count Philadelphia Chromosome Prognosis Translocation, Genetic |
title | Haematological classification of the chronic myeloid leukaemias |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T12%3A40%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Haematological%20classification%20of%20the%20chronic%20myeloid%20leukaemias&rft.jtitle=Bailli%C3%A8re's%20clinical%20haematology&rft.au=Shepherd,%20Patricia%20C.A.&rft.date=1987-12&rft.volume=1&rft.issue=4&rft.spage=887&rft.epage=906&rft.pages=887-906&rft.issn=0950-3536&rft_id=info:doi/10.1016/S0950-3536(87)80031-8&rft_dat=%3Cproquest_cross%3E78050773%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78050773&rft_id=info:pmid/3332855&rft_els_id=S0950353687800318&rfr_iscdi=true |